DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • India
  • /
  • Healthcare
Author Program NEWCreate Narrative
INDRAMEDCO logo

Indraprastha Medical Corporation Limited Stock Price

NSEI:INDRAMEDCO Community·₹33.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

INDRAMEDCO Share Price Performance

₹0
-504.65 (-100.00%)
​
₹0
-504.65 (-100.00%)
​
Price ₹0
Thu, 10 Sep 26
Share Pricen/a

INDRAMEDCO Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with proven track record and pays a dividend.

1 Risk
4 Rewards
View Full Analysis

Indraprastha Medical Corporation Limited Key Details

₹15.2b

Revenue

₹9.6b

Cost of Revenue

₹5.6b

Gross Profit

₹3.7b

Other Expenses

₹1.9b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
20.51
36.86%
12.34%
5.0%
View Full Analysis

About INDRAMEDCO

Founded
1983
Employees
3000
CEO
Shivakumar Pattabhiraman
WebsiteView website
www.apollohospitals.com/delhi/

Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India.

Recent INDRAMEDCO News & Updates

Recent updates

No updates

Indraprastha Medical Corporation Limited Competitors

APOLLOHOSP logo

Apollo Hospitals Enterprise

Symbol: NSEI:APOLLOHOSP
Market cap: ₹1.3t
543220 logo

Max Healthcare Institute

Symbol: BSE:543220
Market cap: ₹1.0t
MANIPALHOS logo

Manipal Health Enterprises

Symbol: NSEI:MANIPALHOS
Market cap: ₹964.5b
FORTIS logo

Fortis Healthcare

Symbol: NSEI:FORTIS
Market cap: ₹681.3b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide